4//SEC Filing
SACHS BRUCE I 4
Accession 0000875320-24-000158
CIK 0000875320other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:13 PM ET
Size
8.1 KB
Accession
0000875320-24-000158
Insider Transaction Report
Form 4
SACHS BRUCE I
Director
Transactions
- Exercise/Conversion
Common Stock
2024-05-22$93.51/sh+7,073$661,396→ 47,073 total - Sale
Common Stock
2024-05-22$448.00/sh−7,073$3,168,704→ 40,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-05-22−7,073→ 0 totalExercise: $93.51Exp: 2026-05-31→ Common Stock (7,073 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1, which was entered into on 02/12/2024.
- [F2]Fully vested.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001197036
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 4:13 PM ET
- Size
- 8.1 KB